Axsome Therapeutics, Inc (AXSM) is a publicly traded Healthcare sector company. As of October 26, 2026, AXSM trades at $146.14 with a market cap of $7.60B and a P/E ratio of -47.47. AXSM moved -7.02% today. Year to date, AXSM is -20.59%; over the trailing twelve months it is +14.15%. Its 52-week range spans $86.99 to $260.19. Analyst consensus is strong buy with an average price target of $285.88. Rallies surfaces AXSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for AXSM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $146.14 |
| Market Cap | $7.60B |
| P/E Ratio | -47.47 |
| EPS | $-3.74 |
| Dividend Yield | 0.00% |
| 52-Week High | $260.19 |
| 52-Week Low | $86.99 |
| Volume | 1.47M |
| Avg Volume | 0 |
| Revenue (TTM) | $776.57M |
| Net Income | $-191.64M |
| Gross Margin | 0.00% |
17 analysts cover AXSM: 0 strong buy, 16 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $285.88.